Beckman Coulter, one of the leaders in clinical diagnostics, has announced the launch of a new test that addresses the three main barriers currently facing schools, businesses, hospitals and communities with the rollout of mass COVID-19 testing. The new Access SARS-CoV-2 Antig...
|